147 results on '"van Herpen, C M L"'
Search Results
2. Prospective practice survey of management of cetuximab-related skin reactions
3. Informal caregiver well-being during and after patients’ treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study
4. Hoofd-halstumoren
5. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
6. Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brain
7. Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer
8. Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
9. Molecular Tumor Boards: current practice and future needs
10. Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
11. A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion
12. Prospective practice survey of management of cetuximab-related skin reactions
13. [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
14. [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
15. Prospective practice survey of management of cetuximab-related skin reactions
16. Tumoren van de urinewegen
17. Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer
18. Informal caregiver well-being during and after patients’ treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study
19. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT
20. [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
21. Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
22. Pharmacokinetics of sunitinib in an obese patient with a GIST
23. Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma
24. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
25. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
26. Current treatment of renal cell carcinoma
27. Locoregional immunotherapy in cancer patients: Review of clinical studies
28. Imaging tumor biology with Zr-89-cetuximab, O-15-H2O and F-18-FDG PET/CT in patients with advanced colorectal cancer treated with cetuximab monotherapy
29. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT.
30. [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.
31. Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer
32. 18F-FLT PET changes during radio - therapy combined with cetuximab in head and neck squamous cell carcinoma patients
33. Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study
34. Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
35. Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).
36. Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
37. Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer
38. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
39. Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension
40. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
41. A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer
42. A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours
43. Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
44. Phase I clinical evaluation of AZD2171 in combination with gefitinib, in patients with advanced tumors
45. Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study.
46. Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.
47. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).
48. 18F-FLT PET changes during radio - therapy combined with cetuximab in head and neck squamous cell carcinoma patients
49. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study
50. Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.